SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma - Quaterly Results

09 Feb 2024 Evaluate
A fair growth of 24.05% in the revenue at Rs. 1721.01 millions was reported in the December 2023 quarter as compared to Rs. 1387.30 millions during year-ago period.The Net Profit of the company vaulted to 105.35% to Rs. 191.12  millions from Rs. 93.07 millions in the previous quarter.OP of the company witnessed a marginal growth to 276.49 millions from 145.42 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1721.01 1387.30 24.05 4831.14 3701.77 30.51 5274.86 4866.46 8.39
Other Income 36.57 21.13 73.07 92.76 50.78 82.67 61.15 51.97 17.66
PBIDT 276.49 145.42 90.13 652.03 421.20 54.80 573.90 520.43 10.27
Interest 1.42 0.29 389.66 2.52 1.95 29.23 2.18 9.61 -77.32
PBDT 275.07 145.13 89.53 649.51 419.25 54.92 571.72 510.82 11.92
Depreciation 22.02 24.33 -9.49 63.57 72.93 -12.83 97.00 119.60 -18.90
PBT 253.05 120.80 109.48 585.94 346.32 69.19 474.72 391.22 21.34
TAX 61.93 27.73 123.33 138.94 80.74 72.08 112.91 85.61 31.89
Deferred Tax 6.43 0.13 4846.15 5.84 -2.36 -347.46 -8.29 -9.95 -16.68
PAT 191.12 93.07 105.35 447.00 265.58 68.31 361.81 305.61 18.39
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 16.07 10.48 53.27 13.50 11.38 18.62 10.88 10.69 1.74

Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×